We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1402:TWSEFar Eastern New Century Corporation Analysis

Data as of 2026-03-14 - not real-time

NT$27.30

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Far Eastern New Century (1402.TW) is trading at TWD 27.3, which sits below its 20‑day SMA of 28.4 and just above the identified support level of 27.3. The price is under pressure from a bearish MACD histogram and a sub‑50 RSI of 39.8, suggesting short‑term oversold conditions, while volume is trending higher, indicating some buying interest. The stock offers an attractive 5.86% dividend yield, but the payout ratio is near 96%, raising concerns about sustainability given the company’s high debt‑to‑equity ratio of 89.5% and a modest ROE of 5.7%. Volatility is elevated at over 27% (30‑day), though beta remains low (0.18‑0.29), reflecting limited market‑wide risk. The fundamentals show a -8.6% revenue decline and thin margins (gross 20.4%, operating 6.3%), while the DCF‑derived fair value of 25.7 is below the current price, hinting at slight overvaluation. Nevertheless, the company’s diversified operations across textiles, petrochemicals, and real estate provide a buffer, and the high dividend makes it a value‑oriented play despite the debt load and earnings pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at 27.3
  • Bearish MACD and RSI indicating limited upside
  • High dividend yield attracting income‑seeking investors

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Negative revenue growth and high debt levels
  • Valuation close to fair value with modest upside
  • Dividend sustainability concerns due to high payout ratio

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Diversified business segments providing resilience
  • Low beta suggesting stable long‑term price behavior
  • Potential pressure on earnings and cash flow from debt servicing

Key Metrics & Analysis

Financial Health

Revenue Growth-8.60%
Profit Margin3.29%
P/E Ratio16.4
ROE5.71%
ROA1.71%
Debt/Equity89.51
P/B Ratio0.7
Op. Cash FlowNT$44.5B
Free Cash FlowNT$26.4B

Technical Analysis

TrendNeutral
RSI39.8
SupportNT$27.30
ResistanceNT$31.65
MA 20NT$28.40
MA 50NT$28.24
MA 200NT$28.99
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueNT$25.67
GradeFair
TypeValue
Dividend Yield5.86%

Risk Assessment

Beta0.29
Volatility27.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.